Marketing

Pharma branding agencies are using AI platforms to craft standout drug names while avoiding risk and streamlining time to market.

Semafor’s rise shows publishers are supplementing inconsistent ad revenues with events and sponsorships.

Roku’s $2.99 ad-free service challenges ad-heavy models, eyeing a forgotten tier between FAST and pricey subs.

Simpler sponsorship tools and wider access help brands tap into engaged, purchase-ready listeners.

47% of marketers worldwide say better attribution and measurement is the top benefit of integrating martech and adtech systems, according to an August survey from EMARKETER and Zeta Global.

Alphabet’s $3.88 trillion valuation signals a new race—where scale, systems, and control beat shiny devices.

45% of US adults say pleasant and happy visuals in pharma ads are misleading, according to November 2025 data from SiriusXM Media.

Despite its scale, ChatGPT isn’t making money—ads are now a must, but integration without disruption is key.

As AI platforms become the first stop, not showing up in answers means not being seen—at all

Roku and iSpot integration marks tighter CTV attribution loop: iSpot’s product aims to lessen intermediaries between ad spending and performance data.

Agentic AI is expanding across ad platforms; CES reveals acceleration in autonomous planning and optimization, even as many marketers hesitate to trust full automation.

PayPal rolled out Transaction Graph Insights & Measurement at CES to gives advertisers and merchants a clearer, cross-merchant view of how people actually shop and purchase—and early results suggest meaningful impact.

OpenAI seeks real consumer intent, and a potential Pinterest acquisition would give OpenAI first-party shopping signals and native ad infrastructure to rival Google and Meta.

48% of worldwide B2B marketers say interactive experiences, live/virtual events, and video content make thought leadership more impactful, according to July 2025 data from Ascend2 and TopRank Marketing.